UDI compliance Solution, UDI for class 1 2 3 Medical Devices
- Freyr Global Regulatory Solutions
- Jan 9, 2018
- 1 min read
Beginning September 24, 2014 and going forward, all medical device manufacturers are required to meet the FDA mandated UDI compliance for their Class I, II and III devices, in phases.
The primary concern facing companies is how to navigate across some of the major challenges in the process of meeting the strict FDA timelines.
Unidentified DI/ PI Sources & Data Configuration
Inaccurate Document Version Control
Error-prone Manual Data Submissions
Non-existent Data Validation System
Incompatible Publishing & Reporting
Effectively handling large volumes of unstructured data from disparate and non-authenticated sources is one of the biggest challenges for manufacturers in meeting their UDI compliance obligations. Add to that the lack of version control measures, cumbersome manual submission, and inadequate data management process making the challenges far greater to handle.
With the timelines getting shorter every day, companies are looking out for a right partner with an effective solution to successfully navigate through the UDI landscape. Freyr IDENTITY leverages the plan, process and training methodology to offer an end-to-end UDI compliance solutions.
Suitable for a company of any size with any number of devices, Freyr IDENTITY is exclusively designed to streamline the complete compliance process by connecting disparate internal functions and integrating data sources and formatted information with a centralized database for automated XML generation and submission that meets all the FDA regulated UDI mandates.
Freyr IDENTITY ensures reliable Regulatory compliance with GxP practice 21 CFR Part 11, including additional compliance capabilities like Version control, Validation, XML Conversion based on SPL and HL7 protocols, as well as Publishing and Printing to enable accurate, efficient and faster UDI compliance.
Комментарии